Dear Everyday Health, Thank you for the opportunity to contribute to your article on at-home molecular COVID tests. I'm Robert W. Buckingham, Dr.P.H., Professor Emeritus of Public Health at the University of Michigan. For the past five decades I've worked in global public health and hospice care, and more recently I've published several scientific papers on COVID-19. I also serve on the ASPHER-WHO COVID-19 Task Force, where we continue to evaluate pandemic responses across Europe and beyond. From my perspective as a public health scientist, I can explain in plain terms how molecular home tests work, how they differ from the rapid antigen kits people are familiar with, and who benefits most from them — particularly vulnerable individuals who need quick and reliable confirmation. I can also comment on what the FDA's recent changes to Emergency Use Authorization mean for the future of these tests and their role in public health. I'd be glad to share insights for your piece and make the science as clear and accessible as possible for your readers. Regards, Robert W. Buckingham, Dr.P.H. Professor Emeritus of Public Health, University of Michigan
Neonatologist and Paediatrician at Marwellus Clinic & Diagnostics
Answered 7 months ago
As the landscape of COVID-19 continues to evolve, at-home molecular COVID-19 tests have emerged as a vital tool for families seeking reassurance and timely, accurate information. These tests utilize advanced nucleic acid amplification methods—including RT-PCR and isothermal technologies—to detect the genetic material of the COVID-19 virus from a simple nasal or saliva sample processed within the home. Unlike rapid antigen tests, which detect viral proteins and are generally less sensitive, molecular tests are engineered to find even tiny amounts of viral genetic material. This means greater accuracy, especially when early detection is essential, and faster results—often in under an hour. Individuals experiencing symptoms gain clarity, allowing prompt medical consultation and isolation if needed. High-risk populations—including those with chronic illnesses or compromised immune systems—can confidently monitor their status. Families and caregivers save time by testing children and household members before travel, events, or returning to school, promoting community safety. FDA regulations have recently shifted, requiring manufacturers to update standards for at-home tests. Consumers should always confirm whether a test is FDA authorized; using approved products ensures reliability and trust. As a neonatologist and pediatrician, I have seen firsthand how access to home-based diagnostics empowers parents and enhances timely care for children. For best results, families should combine at-home testing with guidance from healthcare professionals, especially when medical histories are complex. At-home molecular COVID tests represent a vital resource supporting public health, family safety, and peace of mind. Staying informed and choosing FDA-listed products enables everyone to navigate this evolving landscape with greater confidence. Dr. Sankeerth Yellinedi is a board-certified neonatologist and pediatrician at Marwellus Clinic & Diagnostics, Hyderabad. He stays up-to-date on public health policy and diagnostic innovations to provide families with medically sound advice.
At-home molecular COVID tests use advanced nucleic acid amplification technology such as PCR or isothermal amplification to detect the genetic material of the SARS-CoV-2 virus from a nasal or saliva sample. These tests are generally more sensitive than rapid antigen tests and can identify infection even when viral levels are low, which helps detect asymptomatic cases early. They work by amplifying the virus's RNA if present and typically deliver digital results in under an hour through a portable analyzer. The most appropriate users for at-home molecular tests are individuals who require highly accurate and early detection. This includes people with symptoms, those with known exposure, and vulnerable populations in high-risk settings. They are also valuable for situations such as travel or returning to work, where reliable and timely results are essential. Following the FDA's adjustment to emergency use status, many at-home molecular tests underwent a re-authorization process to remain available. The FDA now requires that products meet updated performance and safety standards. Most leading at-home PCR or NAAT tests continue to be accessible with clear labeling about their intended use. Users should carefully follow instructions and consult healthcare providers for positive or inconclusive results to ensure responsible self-testing and appropriate follow-up care.